These sales are immaterial and routine — likely liquidity-driven following derivative exercises. No bearish signal. Monitor for any upcoming clinical data readouts or corporate events that could move the stock, but this cluster alone does not warrant action.
Price Chart
Executive Summary
Two C-suite insiders at Enliven Therapeutics (ELVN) sold a combined $127K in open-market transactions on July 17, 2026. The CFO and CMO both sold shares, with the CMO's sales totaling ~$108K and the CFO's ~$19K. These sales follow derivative exercises (non-cash) and represent a trivial 0.004% of the $3.3B market cap, making them routine liquidity events with no bearish signal.
Key Financial Metrics
Key Facts
- CFO Benjamin Hohl sold 369 shares for ~$19K on July 17
- CMO Helen Louise Collins sold ~2,100 shares for ~$108K on July 17
- Both executives also exercised derivatives (non-cash) on the same day
- Total open-market sales of ~$127K represent 0.004% of ELVN's $3.3B market cap
- Sales are trivial relative to market cap and likely liquidity-driven after option exercises
Financial Impact
Total insider sales of ~$127K, or 0.004% of market cap
Risk Factors
- Insider sales could be misinterpreted as bearish by retail traders
- Future clinical trial results could introduce volatility independent of insider activity
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ELVN-1784700358211 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | Insider Cluster | $41.93 | awaiting T+5 | — | $43.69 (+4.20%) |
Oct 19, 2026 7d ago | 144 | $41.25 | awaiting T+5 | — | $43.69 (+5.92%) |
Oct 16, 2026 10d ago | 3 | $38.70 $41.49 | ▲ +7.21% | ▲ +7.35% | $43.69 (+12.89%) |
Oct 14, 2026 12d ago | 8-K | $39.33 $41.93 | ▲ +6.61% | ▲ +7.63% | $43.69 (+11.09%) |
Sep 21, 2026 5w ago | Insider Cluster | $48.19 $46.51 | ▼ −3.49% | ▼ −2.30% | $43.69 (−9.34%) |
Sep 4, 2026 7w ago | 144 | $59.32 $54.43 | ▼ −8.24% | ▼ −7.03% | $43.69 (−26.35%) |
Aug 19, 2026 9w ago | Insider Cluster | $58.97 $60.50 | ▲ +2.59% | ▲ +1.48% | $43.69 (−25.91%) |
Aug 9, 2026 11w ago | Institutional Cluster | $59.42 $59.54 | ▲ +0.19% | ▲ +0.24% | $43.69 (−26.47%) |
Jul 21, 2026 13w ago | Insider Cluster | $52.85 $52.97 | ▲ +0.23% | ▲ +2.63% | $43.69 (−17.33%) |
Jun 22, 2026 18w ago | 144 | $48.60 $50.85 | ▲ +4.63% | ▲ +3.62% | $43.69 (−10.10%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers